Role of immune dysfunction in pathogenesis of type 1 diabetes mellitus in children

Asian Pacific Journal of Tropical Medicine

Volumn 7, Issue 10, 2014, Pages 823-826

  He, Jin Shui ^a   Xie, Pu Song ^a   Luo, Dao Shu ^a   Sun, Cheng Jun ^b   Zhang, Yu Gui ^a   Liu, Fu Xing ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Chemokine; Cytokine; Regulatory T cell; Type 1 diabetes mellitus

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CELL CULTURE; CELL ISOLATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE FUNCTION TEST; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SUPERNATANT; UPREGULATION;

EID: 84905964886     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(14)60144-9     Document Type: Article

References (18)

1. Ginter E, Simko V Global prevalence and future of diabetes mellitus. Adv Exp Med Biol 2012, 771:35-41.
2. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, EURODIAB Study Group Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009, 373(9680):2027-2033.
3. Thunander M, Petersson C, Jonzon K, Fornander J, Ossiansson B, Torn C, et al. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res Clin Pract 2008, 82(2):247-255.
4. Ezquer F1, Ezquer M, Contador D, Ricca M, Simon V, Conget P The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment. Stem Cells 2012, 30(8):1664-1674.
5. + stem cells-reconstituted NOD-scid IL2rγnull mice. PLoS One 2014, 9(3):e90387.
6. Chatzigeorgiou A, Harokopos V, Mylona-Karagianni C, Tsouvalas E, Aidinis V, Kamper EF The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time. Ann Med 2010, 42(6):426-438.
7. Galleri L, Sebastiani G, Vendrame F, Grieco FA, Spagnuolo I, Dotta F Viral infections and diabetes. Adv Exp Med Biol 2012, 771:252-271.
8. Ting C, Bansal V, Batal I, Mounayar M, Chabtini L, El Akiki G, et al. Impairment of immune systems in diabetes. Adv Exp Med Biol 2012, 771:62-75.
9. Alberti KG, Zimmet PZ I Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15(7):539-553.
10. Eyerich K, Novak N Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy 2013, 68(8):974-982.
11. Fisman EZ, Adler Y, Tenenbaum A Biomarkers in cardiovascular diabetology: interleukins and matrixins. Adv Cardiol 2008, 45:44-64.
12. Graves DT, Naguib G, Lu H, Leone C, Hsue H, Krall E Inflammation is more persistent in type 1 diabetic mice. J Dent Res 2005, 84(4):324-328.
13. Meagher C, Arreaza G, Peters A, Strathdee CA, Gilbert PA, Mi QS, et al. CCL4 protects from type 1 diabetes by altering islet beta-cell-targeted inflammatory responses. Diabetes 2007, 56(3):809-817.
14. Ellina O, Chatzigeorgiou A, Kouyanou S, Lymberi M, Mylona-Karagianni C, Tsouvalas E, et al. Extracellular matrix-associated (GAGs, CTGF), angiogenic (VEGF) and inflammatory factors (MCP-1, CD40, IFN-γ) in type 1 diabetes mellitus nephropathy. Clin Chem Lab Med 2012, 50(1):167-174.
15. Sia C Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus. Rev Diabet Stud 2005, 2(4):182-186.
16. + regulatory T cells and promote airway tolerance. J Exp Med 2013, 210(4):775-788.
17. Peterson RA Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression. Toxicol Pathol 2012, 40(2):186-204.
18. Łuczyński W, Stasiak-Barmuta A, Juchniewicz A, Wawrusiewicz-Kurylonek N, Iłendo E, Kos J, et al. The mRNA expression of pro- and anti-inflammatory cytokines in T regulatory cells in children with type 1 diabetes. Folia Histochem Cytobiol 2010, 48(1):93-100.